According to the Zhitong Finance App, Cansino Biotech (06185.HK) announced its results for the first three quarters of 2026, achieving operating income of 882 million yuan for the nine months ending September 30, 2026, an increase of 27.4%; net profit attributable to shareholders of listed companies was 16.2913 million yuan, an increase of 12.82% over the previous year. Basic earnings per share were $0.07.

Zhitongcaijing · 10/27 11:33
According to the Zhitong Finance App, Cansino Biotech (06185.HK) announced its results for the first three quarters of 2026, achieving operating income of 882 million yuan for the nine months ending September 30, 2026, an increase of 27.4%; net profit attributable to shareholders of listed companies was 16.2913 million yuan, an increase of 12.82% over the previous year. Basic earnings per share were $0.07.